SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Themis Biosyn informs about clarification

23 Sep 2025 Evaluate
Gujarat Themis Biosyn has informed that the Company has, at all times, made timely and adequate disclosures of all material information/events that may have a bearing on the operations/ performance of the Company, as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

320.55 -2.40 (-0.74%)
24-Apr-2026 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.45
Dr. Reddys Lab 1317.80
Cipla 1289.50
Zydus Lifesciences 930.15
Lupin 2317.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×